Skip to content

Clinical trials

Observational Psoriasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psoriasis Phase: Observational Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20203
20212
20223
20232
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting2
Recruiting2
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Chongli Yu2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2
Xijing Hospital2
Bristol-Myers Squibb1
Chao Ji1
Chinese PLA General Hospital1
First Hospital of China Medical University1
Gang Wang, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psoriasis18
Bone Diseases, Metabolic2
Arthritis, Rheumatoid1
COVID-191
Disease1
Eczema1
Hypertension1
Insulin Resistance1
Spondylitis, Ankylosing1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.